Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.

Drapier S, Gillioz AS, Leray E, Péron J, Rouaud T, Marchand A, Vérin M.

Parkinsonism Relat Disord. 2012 Jan;18(1):40-4. doi: 10.1016/j.parkreldis.2011.08.010. Epub 2011 Sep 3.

PMID:
21890396
2.

Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation.

Rouaud T, Dondaine T, Drapier S, Haegelen C, Lallement F, Péron J, Raoul S, Sauleau P, Vérin M.

Mov Disord. 2010 Sep 15;25(12):1839-46. doi: 10.1002/mds.23171.

PMID:
20568094
3.

Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.

De Gaspari D, Siri C, Landi A, Cilia R, Bonetti A, Natuzzi F, Morgante L, Mariani CB, Sganzerla E, Pezzoli G, Antonini A.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):450-3.

4.

Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.

Paek SH, Han JH, Lee JY, Kim C, Jeon BS, Kim DG.

Neurosurgery. 2008 Nov;63(5):925-36; discussion 936-7. doi: 10.1227/01.NEU.0000334045.43940.FB.

PMID:
19005383
5.
6.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
7.

Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.

Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY.

Stereotact Funct Neurosurg. 2009;87(4):241-8. doi: 10.1159/000225977. Epub 2009 Jun 26.

PMID:
19556833
8.

SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.

Nunta-Aree S, Sitthinamsuwan B, Boonyapisit K, Pisarnpong A.

J Med Assoc Thai. 2010 May;93(5):529-40.

PMID:
20524438
9.

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.

Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C, Artusi CA, Arduino N, Marchisio A, Lanotte M, Rizzone M, Lopiano L.

Mov Disord. 2011 Nov;26(13):2327-34. doi: 10.1002/mds.23903. Epub 2011 Aug 25.

PMID:
22012750
10.

Comparison of pallidal and subthalamic nucleus deep brain stimulation for advanced Parkinson's disease: results of a randomized, blinded pilot study.

Burchiel KJ, Anderson VC, Favre J, Hammerstad JP.

Neurosurgery. 1999 Dec;45(6):1375-82; discussion 1382-4.

PMID:
10598706
11.

Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P.

N Engl J Med. 2003 Nov 13;349(20):1925-34.

12.

Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.

Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ.

Arch Neurol. 2006 Jul;63(7):951-5.

PMID:
16831963
13.

Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.

Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.

Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.

PMID:
19174620
14.

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP.

Arch Neurol. 2005 Apr;62(4):554-60.

PMID:
15824252
15.

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, Gerstner A, Berger K, Hellwig D, Deuschl G, Freund HJ, Oertel WH, Dodel RC.

J Neurol. 2002 Jun;249(6):759-66.

PMID:
12111311
16.

Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.

Kim HJ, Paek SH, Kim JY, Lee JY, Lim YH, Kim DG, Jeon BS.

Mov Disord. 2009 Feb 15;24(3):329-35. doi: 10.1002/mds.22211.

PMID:
19006187
17.

[Significant improvement of motor symptoms by deep brain stimulation of bilateral subthalamic nucleus in patients with moderate or advanced Parkinson's disease].

Chen J, Liu JL, Chen X, Qian H, Xian WB, Zhou HY, Liu YM, Ye XF, Zheng YF, Zhang SL, Chen L, Li JR, Liu ZL, Pei Z.

Zhonghua Yi Xue Za Zhi. 2011 Feb 1;91(5):291-5. Chinese.

PMID:
21419000
18.

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL.

N Engl J Med. 1998 Oct 15;339(16):1105-11.

19.

Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation.

Elia AE, Dollenz C, Soliveri P, Albanese A.

Eur J Neurol. 2012 Jan;19(1):76-83. doi: 10.1111/j.1468-1331.2011.03437.x. Epub 2011 Jun 4.

PMID:
21645174
20.

Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.

Alegret M, Valldeoriola F, Martí M, Pilleri M, Junqué C, Rumià J, Tolosa E.

Mov Disord. 2004 Dec;19(12):1463-9.

PMID:
15390065

Supplemental Content

Support Center